Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q3 2022
Institutional positions in Silence Therapeutics plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +4 vs. Q2 2022
- Shares held
- 18.7M
- +8.29M (+80.0%) vs. Q2 2022
- Total value
- $183.4M
- +$67.0M (+57.6%) vs. Q2 2022
- New holders
- 7
- 9 more added
- Sold out
- 3
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 500 | $5.00K | 0.00% | +500 | New |
| Deutsche Bank AG | 3,953 | $40.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 13,177 | $130.0K | 0.00% | +13,177 | New |
| Millennium Management LLC | 14,557 | $144.0K | 0.00% | +14,557 | New |
| Citadel Advisors LLC | 22,851 | $226.0K | 0.00% | +11,410+99.7% | Added |
| WS Management LLLP | 25,000 | $251.0K | 0.04% | 00.0% | Unchanged |
| Blair William & Co | 41,887 | $420.0K | 0.00% | −9,288−18.1% | Reduced |
| Citigroup Inc | 58,333 | $576.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 65,815 | $660.0K | 0.00% | −3,440−5.0% | Reduced |
| Great Point Partners LLC | 68,915 | $692.0K | 0.17% | −332,534−82.8% | Reduced |
| UBS Oconnor LLC | 79,636 | $786.0K | 0.01% | +50,820+176.4% | Added |
| SG Americas Securities, LLC | 98,953 | $977.0K | 0.01% | −2,500−2.5% | Reduced |
| Woodline Partners LP | 115,120 | $1.16M | 0.02% | +115,120 | New |
| Parkman Healthcare Partners LLC | 127,458 | $1.28M | 0.36% | +101,208+385.6% | Added |
| Morgan Stanley | 155,159 | $1.56M | 0.00% | +1,866+1.2% | Added |
| HSBC Holdings PLC | 177,834 | $1.75M | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 209,886 | $2.11M | 0.05% | −1,574−0.7% | Reduced |
| Point72 Asset Management, L.P. | 550,875 | $5.53M | 0.02% | +300,875+120.4% | Added |
| AXA S.A. | 641,666 | $6.44M | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 660,000 | $6.62M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $7.03M | 0.02% | +135,000+23.9% | Added |
| Frazier Life Sciences Management, L.P. | 881,173 | $8.70M | 0.67% | 00.0% | Unchanged |
| Aquilo Capital Management, LLC | 1,263,125 | $12.7M | 5.33% | +1,263,125 | New |
| BVF Inc | 1,508,416 | $14.9M | 0.61% | +841,750+126.3% | Added |
| Deep Track Capital, LP | 1,951,580 | $19.6M | 0.97% | +1,000,000+105.1% | Added |
| TCG Crossover Management, LLC | 2,104,875 | $21.1M | 6.34% | +2,104,875 | New |
| Lombard Odier Asset Management (Europe) Ltd | 3,219,400 | $32.3M | 1.68% | +3,219,400 | New |
| Lombard Odier Asset Management (USA) Corp | 3,896,595 | $35.7M | 5.12% | +130,226+3.5% | Added |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −634,270−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −30,483−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −120−100.0% | Sold out |